4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (CAS 3680-69-1): An Essential Intermediate in Tofacitinib Development
Introduction
The synthesis of modern pharmaceutical compounds depends on the availability of high-quality chemical intermediates. Among these, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (CAS No. 3680-69-1) plays a significant role in the production of Tofacitinib, an important active pharmaceutical ingredient used in the treatment of autoimmune disorders.
Role in Pharmaceutical Chemistry
Heterocyclic compounds such as pyrrolo-pyrimidine derivatives are widely used in medicinal chemistry due to their structural versatility and biological relevance. 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine serves as a valuable building block during the multi-step synthesis of Tofacitinib, contributing to both process efficiency and product consistency.
Applications in API Manufacturing
This compound is primarily utilized as a Tofacitinib intermediate, supporting large-scale API manufacturing as well as pharmaceutical research and development. Its chemical stability and reactivity profile make it suitable for controlled synthesis processes required by the pharmaceutical industry.
Quality Considerations
The effectiveness of any pharmaceutical intermediate depends heavily on purity and batch-to-batch consistency. Manufacturers supplying 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine must adhere to strict quality standards to ensure reliable performance in downstream drug synthesis.
Industry Perspective
With the growing global demand for autoimmune therapies, the need for dependable Tofacitinib intermediates continues to rise. Pharmaceutical companies increasingly partner with experienced chemical manufacturers who can deliver high-quality intermediates while meeting regulatory and compliance expectations.
About Vidgastech
Vidgastech is a specialized manufacturer and supplier of pharmaceutical intermediates, including intermediates used in Tofacitinib synthesis. The company focuses on quality-driven manufacturing, technical expertise, and reliable supply solutions for pharmaceutical and research organizations worldwide.
Conclusion
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (3680-69-1) remains an essential component in the synthesis of Tofacitinib. As pharmaceutical manufacturing evolves, the role of trusted intermediate suppliers like Vidgastech becomes increasingly important in supporting safe and efficient drug development.